Key result
Pharmacological inhibition of Cox2 activity with NS-398 or Celecoxib suppressed cardiomyocyte proliferation by approximately 70% and 50%, respectively, during early zebrafish heart regeneration.
Why the study?
The dynamics of prostaglandin E2 signaling in the context of heart regeneration remain underexplored despite its role in promoting regeneration and cell proliferation.
Does pharmacological inhibition of Cox2 reduce cardiomyocyte proliferation and PGE2 production in adult zebrafish following cardiac injury?
Does pharmacological inhibition of Cox2 reduce cardiomyocyte proliferation and PGE2 production in adult zebrafish following cardiac injury?
In a zebrafish model of heart regeneration, injury-induced PGE2 signaling via Cox2 is essential for stimulating cardiomyocyte proliferation.
Should not change clinical Cox2 inhibitor use; leaves open its role in mammalian cardiac regeneration.
The inability to effectively stimulate cardiomyocyte proliferation remains a principle barrier to regeneration in the adult human heart. A tightly regulated, acute inflammatory response mediated by a range of cell types is required to initiate regenerative processes. Prostaglandin E2 (PGE2), a potent lipid signaling molecule induced by inflammation, has been shown to promote regeneration and cell proliferation; however, the dynamics of PGE2 signaling in the context of heart regeneration remain underexplored. Here, we employ the regeneration-competent zebrafish to characterize components of the PGE2 signaling circuit following cardiac injury. In the regenerating adult heart, we documented an increase in PGE2 levels, concurrent with upregulation of cox2a and ptges, two genes critical for PGE2 synthesis. Furthermore, we identified the epicardium as the most prominent site for cox2a expression, thereby suggesting a role for this tissue as an inflammatory mediator. Injury also drove the opposing expression of PGE2 receptors, upregulating pro-restorative ptger2a and downregulating the opposing receptor ptger3. Importantly, treatment with pharmacological inhibitors of Cox2 activity suppressed both production of PGE2, and the proliferation of cardiomyocytes. These results suggest that injury-induced PGE2 signaling is key to stimulating cardiomyocyte proliferation during regeneration.
No takes yet. Share an insight, caveat, or question.
FitzSimons et al. (2020) studied Cardiac injury and regeneration. Cox2 inhibitors (NS-398 or Celecoxib) vs. Vehicle control (0.1% DMSO or 0.44% EtOH) was evaluated on Cardiomyocyte proliferation index at 3 days post-amputation (p=<0.05). Pharmacological inhibition of Cox2 activity with NS-398 or Celecoxib suppressed cardiomyocyte proliferation by approximately 70% and 50%, respectively, during early zebrafish heart regeneration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: